Outcomes of highly active antiretroviral therapy and its predictors: a cohort study focusing on tuberculosis co-infection in South West Ethiopia-Reference-Cited by-同舟云学术

Outcomes of highly active antiretroviral therapy and its predictors: a cohort study focusing on tuberculosis co-infection in South West Ethiopia

Published:2015-09-15 Issue:1 Volume:8 Page:
ISSN:1756-0500
Container-title:BMC Research Notes
language:en
Short-container-title:BMC Res Notes

Author:

Lenjisa Jimma Likisa,Wega Sultan Suleman,Lema Tefera Belachew,Ayana Gemeda Abebe

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13104-015-1417-0

Reference33 articles.

1. World Health Organization. Priority research questions for TB/HIV in HIV-prevalent and resource-limited settings. Geneva, Switzerland: WHO; 2010. http://www.whoint/gtb . Accessed 15 November 2011.

2. World Health Organization (WHO) Stop TB Department and Department of HIV/AIDS. TB/HIV a Clinical Manual. Geneva, Switzerland: WHO. 2004. http://www.who.int/gtb . Accessed 6 December 2011.

3. World Health Organization, TB/HIV FACTS 2011–2012. Geneva; Switzerland. WHO. 2012. http://www.who.int/tb/publications/TBHIV_Facts_for_2011.pdf . Accessed 29 August 2012.

4. Abera B, Kate F, Zelalem H. The association of TB with HIV infection in Oromia Regional State, Ethiopia in 2006/7. Ethiop J Health Dev. 2009;23(1):63–7.

5. Kwara A, Flanigan TP, Carter EJ. Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status. Int J Tuberc Lung Dis. 2005;9(3):248–57.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second-Line Antiretroviral Treatment Outcome in HIV-Infected Patients Coinfected with Tuberculosis in Pakistan;BioMed Research International;2023-04-19

2. Factors associated with first-line antiretroviral treatment failure in adult HIV-positive patients: a case-control study from Ethiopia;BMC Infectious Diseases;2019-06-18

3. Immunological outcomes after six months with first line antiretroviral therapy: a lesson from Yogyakarta, Indonesia;The Journal of Infection in Developing Countries;2018-05-31